Consensus Teladoc Health, Inc.

Equities

TDOC

US87918A1051

Healthcare Facilities & Services

Market Closed - Nyse Other stock markets 04:00:02 2024-12-10 pm EST			5-day change	1st Jan Change
10.60 ^USD	-0.84%		-7.83%	-50.81%

Nov. 25	Sector Update: Health Care Stocks Advance Late Afternoon	MT
Nov. 25	Sector Update: Health Care	MT

Evolution of the Average Target: Teladoc Health, Inc.

average-target-price-chart TELADOC-HEALTH-INC

Evolution of the Target Price: Teladoc Health, Inc.

target-price-consensus-chart TELADOC-HEALTH-INC

Changes in Analyst Recommendations: Teladoc Health, Inc.

29dc.w6CwDG1z5Cyy1OgxxGdrayYEkN_XSgfMC_-vOW-0YUc.lsbgQCxGyUf-lZ1jqhM0XWpm1LCIO0CIfM-bawLMUB-0y8h1VTucVMG63A~5fb63b267db2a5bdd2713bc54b6ea454

Analysts' recommendations: Teladoc Health, Inc.

Deutsche Bank Raises Price Target on Teladoc Health to $12 From $10, Keeps Hold Rating	Nov. 01	MT
RBC Lifts Price Target on Teladoc Health to $10 From $9, Keeps Outperform Rating	Oct. 09	MT
Analyst recommendations: Amazon, Tesla, AMD, Kellanova, Nvidia...	Aug. 06
UBS Adjusts Price Target on Teladoc to $9 From $16, Maintains Neutral Rating	Aug. 05	MT
Truist Adjusts Teladoc's PT to $10 From $15, Keeps Hold Rating	Aug. 02	MT
Deutsche Bank Cuts Teladoc Price Target to $10 From $15, Maintains Hold Rating	Aug. 02	MT
Oppenheimer Adjusts Teladoc Price Target to $17 From $21, Maintains Outperform Rating	Aug. 01	MT
RBC Adjusts Teladoc's PT to $9 From $18, Keeps Outperform Rating	Aug. 01	MT
Analyst recommendations: Etsy, Meta Platforms, Ebay, Fair Isaac, KKR...	Aug. 01
Analyst recommendations: Sirius Xm, Tesla, Chipotle, Spotify, Walgreens Boots...	Jul. 25
Evercore ISI Lowers Price Target on Teladoc to $10 From $14, Maintains In Line Rating	Jul. 09	MT
Deutsche Bank Adjusts Teladoc Price Target to $15 From $16, Maintains Hold Rating	Jun. 12	MT
JPMorgan Adjusts Teladoc Price Target to $16 From $19, Maintains Neutral Rating	May. 21	MT
Truist Securities Cuts Teladoc's Price Target to $15 From $17, Maintains Hold Rating	Apr. 29	MT
UBS Adjusts Teladoc Price Target to $16 From $20, Maintains Neutral Rating	Apr. 26	MT
Oppenheimer Cuts Teladoc's Price Target to $21 From $26, Maintains Outperform Rating	Apr. 26	MT
Deutsche Bank Cuts Teladoc's Price Target to $18 From $22, Maintains Hold Rating	Apr. 08	MT
Leerink Partners Initiates Coverage on Teladoc With Market Perform Rating, $17 Price Target	Feb. 26	MT
Deutsche Bank Adjusts Teladoc Price Target to $22 From $23, Maintains Hold Rating	Feb. 22	MT
Citigroup Adjusts Teladoc Price Target to $19 From $21, Maintains Neutral Rating	Feb. 21	MT
Barclays Trims Price Target on Teladoc to $25 From $26, Maintains Overweight Rating	Feb. 21	MT
Canaccord Genuity Lowers Price Target on Teladoc to $28 From $34, Maintains Buy Rating	Feb. 21	MT
Piper Sandler Adjusts Price Target on Teladoc to $25 From $30, Maintains Overweight Rating	Feb. 21	MT
RBC Cuts Price Target on Teladoc to $25 From $30, Notes 'Slower Expected Revenue Trajectory,' Keeps Outperform Rating	Feb. 21	MT
JPMorgan Adjusts Price Target on Teladoc to $19 From $33, Maintains Neutral Rating	Nov. 17	MT

More recommendations

Sector Comparison:

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analyst Opinion	4m Revision of opinion	Divergence of analysts' opinions	Divergence of Target Price	Ecart obj. / dr
	TELADOC HEALTH, INC.					+1.96%
	HIMS & HERS HEALTH, INC.					-23.68%
	TALKSPACE, INC.					+42.96%
	AMERICAN WELL CORPORATION					+29.20%
	Average					+12.61%
	Weighted average by Cap.					-14.04%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

10.60USD

Average target price

10.90USD

Spread / Average Target

+2.83%

High Price Target

14.00USD

Spread / Highest target

+32.08%

Low Price Target

8.000USD

Spread / Lowest Target

-24.53%

Analyst Consensus Detail

consensus-detail-chart TELADOC-HEALTH-INC

Consensus revision (last 18 months)

consensus-revision-chart TELADOC-HEALTH-INC

Analysts covering the company

Deutsche Bank Securities
RBC Capital Markets
JPMorgan Chase
Truist Securities
UBS
Oppenheimer
Leerink Partners
Citigroup
Barclays
Piper Sandler
Canaccord Genuity
Evercore ISI
Stephens Inc.
Credit Suisse
Wells Fargo Securities
SVB Securities LLC
Berenberg Bank
DA Davidson
Guggenheim
KeyBanc Capital Markets
Cowen
Needham & Co.
Goldman Sachs
Stifel Nicolaus
Argus
SVB Leerink
Baird
William Blair & Co.
Craig-Hallum
Jefferies & Co.
BTIG